|
Jul 30
|
Hologic (HOLX) Q3 Earnings Surpass Estimates, Margins Rise
|
|
Jul 29
|
Avantor's (AVTR) Q2 Earnings Beat, Operating Margin Declines
|
|
Jul 29
|
Are Investors Undervaluing Quest Diagnostics (DGX) Right Now?
|
|
Jul 29
|
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer
|
|
Jul 26
|
Integer Holdings (ITGR) Q2 Earnings Top Estimates, Margins Up
|
|
Jul 26
|
DexCom's (DXCM) Q2 Earnings Beat Estimates, Revenues Miss
|
|
Jul 26
|
Hologic (HOLX) Buys Endomag to Boost Breast Cancer Solutions
|
|
Jul 26
|
Amedisys (AMED) Q2 Earnings Top Estimates, Gross Margin Down
|
|
Jul 25
|
Terumo (TRUMY) Unit Reveals WEB 17 Device Effective in Aneurysms
|
|
Jul 25
|
Molina Healthcare (MOH) Q2 Earnings Beat on Growing Membership
|
|
Jul 25
|
Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
|
|
Jul 25
|
Chemed (CHE) Q2 Earnings Miss Estimates, Margins Expand
|
|
Jul 25
|
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
|
|
Jul 24
|
AtriCure (ATRC) Gains China Approval for AtriClip LAA System
|
|
Jul 24
|
Quest Diagnostics' (DGX) Haystack Oncology Forges New MRD Deal
|
|
Jul 24
|
Quest Diagnostics Incorporated's (NYSE:DGX) Intrinsic Value Is Potentially 95% Above Its Share Price
|
|
Jul 24
|
Q2 2024 Quest Diagnostics Inc Earnings Call
|
|
Jul 23
|
Cardinal Health's (CAH) China Syringe Makers Face FDA Warnings
|
|
Jul 23
|
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
|
|
Jul 23
|
Quest Diagnostics (DGX) Q2 Earnings and Revenues Top Estimates
|